missing translation for 'onlineSavingsMsg'
Learn More
Learn More
PPARA Monoclonal Antibody (OTI2D10), TrueMAB™, OriGene
Mouse Monoclonal Antibody
Brand: Origene Technologies TA503529
This item is not returnable.
View return policy
Description
Peroxisome proliferator-activated receptor alpha (PPARA) is a member of the nuclear hormone receptor subfamily. Upon activation, PPARA forms heterodimers with retinoid X receptors (RXRs), and functions to regulatetranscrption of specific gene sequences. In particular, PPARA controls genes involved in the peroxisomal and mitochondrial beta oxidation pathways, fatty acid uptake, and triglyceride catabolism in the liver and skeletal muscle. PPARA also has anti-inflammatory and anti-proliferative effects and prevents the proatherogenic effects of cholesterol accumulation in macrophages by stimulating cholesterol efflux. PPARA is the main target of fibrate drugs; hypolipidemic agents used in the treatment of dyslipidemia and the prevention of cardiovascular disease. They could also be used for the treatment of type II diabetes.Specifications
| PPARA | |
| Monoclonal | |
| 0.48 mg/mL | |
| PBS with 1% BSA, 50% glycerol and 0.02% sodium azide | |
| Q07869 | |
| PPARA | |
| Human recombit protein fragment corresponding to amino acids 145-420 of human PPARA produced in E.coli. | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG1 |
| Flow Cytometry, Immunocytochemistry, Immunofluorescence, Western Blot | |
| OTI2D10 | |
| Unconjugated | |
| PPARA | |
| NR1C1, PPAR, PPARalpha, hPPAR | |
| Mouse | |
| Affinity Chromatography | |
| RUO | |
| 5465 | |
| -20° C, Avoid Freeze/Thaw Cycles | |
| Liquid |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction